November 21, 2024 | NEJM
Image Challenge from the New England Journal of Medicine — November 21, 2024
Related Articles
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of…
Cell-free DNA for Colorectal Cancer Screening | NEJM
Editorial from The New England Journal of Medicine — Cell-free DNA for Colorectal Cancer Screening
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening | NEJM
Original Article from The New England Journal of Medicine — A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
Fight or Flight — Facing the Marburg Outbreak in Rwanda | NEJM
Having diagnosed two ICU patients with the first known cases of Marburg virus disease in Rwanda, a physician must prioritize limiting spread, despite pleas for…
Late-Liver-Stage Attenuated Malaria Vaccine | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Late-Liver-Stage Attenuated Malaria Vaccine
Candida auris Infections | NEJM
C. auris, a serious public health threat that may have emerged because of climate change, persists on human skin and inanimate objects, frequently causing difficult-to-control…
Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma | NEJM
The effect of embolization of the middle meningeal artery in patients with subacute or chronic subdural hematoma is uncertain. We performed a multicenter, open-label, randomized…
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of…
Exclusive: US FDA finds widely used asthma drug impacts the brain
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems…
Sickle Cell Trait, Inequity, and the Need for Change | NEJM
Because of misperceptions about risks, people with sickle cell trait in the United States may receive inequitable and potentially harmful treatment, with implications for autonomy,…